Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2005
06/08/2005EP1536802A1 Shortening of hospital stay and improving survival in patients with chronic kidney disease
06/08/2005EP1536801A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/08/2005EP1536800A1 Synergistic interaction of abacavir and alovudine
06/08/2005EP1536799A1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properties
06/08/2005EP1536798A1 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
06/08/2005EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
06/08/2005EP1536796A1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
06/08/2005EP1536795A1 Inverse agonists acting at virus-encoded g protein-coupled receptors
06/08/2005EP1536794A2 Treatment of rheumatoid arthritis by inhibition of pde4
06/08/2005EP1536793A1 Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases
06/08/2005EP1536792A1 Pramipexole once-daily dosage form
06/08/2005EP1536791A1 Sustained-release tablet comprising reboxetine
06/08/2005EP1536789A1 Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases
06/08/2005EP1536788A1 Pharmaceutical solid dosage forms exhibiting reproductible drug release profile
06/08/2005EP1536787A2 Imidazole alkaloids from lepidium meyenii and methods of usage
06/08/2005EP1536786A1 Combination of an allosteric inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib
06/08/2005EP1536785A2 Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure
06/08/2005EP1536784A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1536783A2 Solid formulations comprising an indolinone compound
06/08/2005EP1536782A1 Synergistic combination of an alpha-2-delta ligand and a pdev inhibitor for use in the treatment of pain
06/08/2005EP1536781A1 Nutritional or pharmaceutical compositions for increasing the creatine response of organisms
06/08/2005EP1536780A1 Oral liquid tolterodine composition
06/08/2005EP1536779A2 Treatment of metastatic breast cancer with anthracyclines and taxanes
06/08/2005EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity
06/08/2005EP1536777A1 Use of nf-kappa b inhibitors for the treatment of mastitis
06/08/2005EP1536775A1 Compositions comprising hmg-coa reductase inhibitor
06/08/2005EP1536771A1 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations
06/08/2005EP1536769A2 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
06/08/2005EP1536768A1 Biodegradable composition with prolonged release of the biological active compound and preparation thereof
06/08/2005EP1536766A1 Method for protecting the skin from aging
06/08/2005EP1536763A2 Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
06/08/2005EP1536759A1 Oral care composition comprising tropolone compounds and essential oils
06/08/2005EP1536749A2 Antibacterial formulations
06/08/2005EP1536698A1 Novel nutraceutical compositions comprising biotin
06/08/2005EP1536684A2 Method for the prevention and/or treatment of atherosclerosis
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1458706A4 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
06/08/2005EP1441769B1 Pharmaceutical formulations containing low concentrations of peroxide for treating or preventing vaginal infections
06/08/2005EP1440075B1 Novel 3beta-amino azabicyclooctane heteroaromatic amide derivatives, preparation method and therapeutic uses thereof
06/08/2005EP1414937B1 Hops extracts, method for the production and use
06/08/2005EP1408981A4 Methods for preventing antipsychotic-induced weight gain
06/08/2005EP1373269B1 Jun kinase inhibitors
06/08/2005EP1373231B1 3-heterocyclyl-propano-hydroxamic acid as pcp inhibitors
06/08/2005EP1370528B1 Mch antagonists and their use in the treatment of obesity
06/08/2005EP1337526B1 Substituted imidazoles useful in the treatment of inflammatory diseases
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP1299109A4 Bifunctional antibiotics
06/08/2005EP1294710B1 Indole derivatives useful for the treatment of cns disorders
06/08/2005EP1289928A4 Novel amorphous form of sertraline hydrochloride
06/08/2005EP1265595B1 Stabilized ascorbic acid solutions
06/08/2005EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1251858B1 Podophyllotoxin compositions
06/08/2005EP1244472B1 Particulate vitamin composition
06/08/2005EP1240285B1 Stabilisation of pigments and polyunsaturated oils and oil concentrates
06/08/2005EP1239844B1 Process for producing nanometer particles by fluid bed spray-drying
06/08/2005EP1231925B1 Method and composition for the treatment of adenoviral ocular infections
06/08/2005EP1223971B1 Compositions for preventing and treating transplant rejection
06/08/2005EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/08/2005EP1189895B1 Thiazole and oxazole derivatives and their pharmaceutical use
06/08/2005EP1176146B1 Carbamoyl tetrahydropyridine derivatives
06/08/2005EP1169441B1 Pharmaceutical compositions for the treatment of heart failure
06/08/2005EP1165031B1 Resorcinol composition
06/08/2005EP1102775B1 Novel phospholipids with unsaturated alkyl and acyl chains
06/08/2005EP1095064B1 Amides of hyaluronic acid and the derivatives thereof and a process for their preparation
06/08/2005EP1089735B1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
06/08/2005EP1068182B1 Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one
06/08/2005EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
06/08/2005EP1040830B1 Remedy for neurodegenerative diseases
06/08/2005EP1024806B1 Use of non-immunosuppressive compounds for promoting nerve regeneration
06/08/2005EP1019045B1 Antithrombotic agents
06/08/2005EP1017391B1 Sustained release tablet formulation to treat parkinson disease
06/08/2005EP1015459B1 Tetrazole-containing rapamycin analogs with shortened half-lives
06/08/2005EP1007013B1 Parenteral pimaricin as treatment of systemic infections
06/08/2005EP1003501B9 Use of an agent for lowering the risk of cardiovascular disease
06/08/2005EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition
06/08/2005EP0983304B1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation
06/08/2005EP0964685B1 Composition and method for treating fungal disease in animals
06/08/2005EP0922029B1 Ether muscarinic antagonists
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1625603A Genetic polymorphisms in the preprotachykinin gene
06/08/2005CN1625597A Novel elongase gene and method for producing polyunsaturated fatty acids
06/08/2005CN1625559A Novel compounds that inhibit factor Xa activity
06/08/2005CN1625558A Aza-arylpiperazines
06/08/2005CN1625557A Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
06/08/2005CN1625556A Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
06/08/2005CN1625555A Quinazoline compounds
06/08/2005CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes
06/08/2005CN1625553A Treatment of male sexual dysfunction
06/08/2005CN1625551A Manufacturing method of 6-aminomethyl-6, 11-dihydro-5H-dibenzo.[b, e] azepine
06/08/2005CN1625549A Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
06/08/2005CN1625548A Purified LASOFOXIFENE and a method for purification of racemic LASOFOXIFENE by recrystallization
06/08/2005CN1625422A Synergistic cocomposition of trans-24-15-carbonyl acid and apocynin and its application
06/08/2005CN1625414A Pharmaceutical composition
06/08/2005CN1625412A Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders
06/08/2005CN1625411A Combination of a NSAID and a PDE-4 inhibitor
06/08/2005CN1625410A 2, 4, 6-triamino-1, 3, 5-triazine derivative
06/08/2005CN1625408A Improved kavalactone profile
06/08/2005CN1625407A Medicine composition comprising arsenite for treatment of malignancy
06/08/2005CN1625406A Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals
1 ... 4663 4664 4665 4666 4667 4668 4669 4670 4671 4672 4673 4674 4675 4676 4677 4678 4679 4680 4681 4682 4683 ... 7860